ABIONYX Pharma SA
No trades
Last report date
Mar 12, 2026
Report period
H2 2025
−0.155 EUR
−5.50 M EUR
4.10 M EUR
33.76 M
About ABIONYX Pharma SA
Sector
Industry
CEO
Cyrille Tupin
Website
Headquarters
Balma
Founded
2005
IPO date
Mar 30, 2015
Identifiers
2
ISIN FR0012616852
ABIONYX Pharma SA engages in the discovery and development of novel therapies for patients without existing or effective treatments. It develops biologics and HDL-derived vectors that target the immune and inflammatory dysregulation underlying sepsis, and other severe diseases. The company was founded by Jean-Louis Dasseux and William F. Brinkerhoff on March 24, 2005 and is headquartered in Balma, France.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of ABNX is 3.225 EUR — it has decreased by −2.83% in the past 24 hours. Watch ABIONYX Pharma SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange ABIONYX Pharma SA stocks are traded under the ticker ABNX.
ABNX stock has fallen by −0.76% compared to the previous week, the month change is a −11.28% fall, over the last year ABIONYX Pharma SA has showed a 158.00% increase.
We've gathered analysts' opinions on ABIONYX Pharma SA future price: according to them, ABNX price has a max estimate of 11.00 EUR and a min estimate of 10.00 EUR. Watch ABNX chart and read a more detailed ABIONYX Pharma SA stock forecast: see what analysts think of ABIONYX Pharma SA and suggest that you do with its stocks.
ABNX reached its all-time high on Jun 1, 2015 with the price of 14.440 EUR, and its all-time low was 0.200 EUR and was reached on Oct 25, 2019. View more price dynamics on ABNX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ABNX stock is 3.76% volatile and has beta coefficient of −0.55. Track ABIONYX Pharma SA stock price on the chart and check out the list of the most volatile stocks — is ABIONYX Pharma SA there?
Today ABIONYX Pharma SA has the market capitalization of 115.12 M, it has decreased by −4.26% over the last week.
Yes, you can track ABIONYX Pharma SA financials in yearly and quarterly reports right on TradingView.
ABIONYX Pharma SA is going to release the next earnings report on Sep 24, 2026. Keep track of upcoming events with our Earnings Calendar.
ABNX net income for the last half-year is −3.19 M EUR, while the previous report showed −2.31 M EUR of net income which accounts for 0.00% change. Track more ABIONYX Pharma SA financial stats to get the full picture.
No, ABNX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ABNX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABIONYX Pharma SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABIONYX Pharma SA technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABIONYX Pharma SA stock shows the buy signal. See more of ABIONYX Pharma SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.